Deva Holding A.S. (IST: DEVA)

Market Cap	12.45B
Revenue (ttm)	10.96B
Net Income (ttm)	2.89B
Shares Out	200.02M
EPS (ttm)	14.45
PE Ratio	4.31
Forward PE	n/a
Dividend	0.25 (0.40%)
Ex-Dividend Date	Jun 25, 2024

Volume	401,875
Open	61.50
Previous Close	61.35
Day's Range	60.85 - 62.85
52-Week Range	60.85 - 106.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2024

About Deva Holding A.S.

Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company provides antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also offers products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, urinary syste...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1958
• Employees: 2,908
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: DEVA

Financial Performance

In 2023, Deva Holding A.S.'s revenue was 11.33 billion, an increase of 30.04% compared to the previous year's 8.71 billion. Earnings were 3.39 billion, an increase of 297.79%.